Newly developed colorimetric drug screening assay for Bacillus anthracis.
Barrow
Esther W
EW
Valderas
Michelle Wright
MW
Bourne
Philip C
PC
Barrow
William W
WW
D000881:Anthrax / Q000188:drug therapy; D001408:Bacillus anthracis / Q000187:drug effects* / Q000472:pathogenicity; D023482:Bioterrorism; D002939:Ciprofloxacin / Q000494:pharmacology; D003124:Colorimetry / Q000379:methods* / Q000592:standards; D004396:Coloring Agents; D004318:Doxycycline / Q000494:pharmacology; D024881:Drug Resistance, Bacterial; D006801:Humans; D066298:In Vitro Techniques; D008826:Microbial Sensitivity Tests / Q000379:methods* / Q000592:standards; D010078:Oxazines; D010406:Penicillins / Q000494:pharmacology; D012015:Reference Standards; D014966:Xanthenes
D004396:Coloring Agents; D010078:Oxazines; D010406:Penicillins; D014966:Xanthenes; C005843:resazurin; D002939:Ciprofloxacin; D004318:Doxycycline